35 min listen
Novel Incretin-Based Dual/Triple Agonists: The Future in Diabetes Care?
FromKeeping Current
ratings:
Length:
21 minutes
Released:
Mar 29, 2024
Format:
Podcast episode
Description
How much do you know about future treatment options for type 2 diabetes (T2D)? Join Drs Vilsbøll and Nauck to find out. Credit available for this activity expires: 03/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000462 ?ecd=bdc_podcast_libsyn_mscpedu
Released:
Mar 29, 2024
Format:
Podcast episode
Titles in the series (99)
Clinical Trials in Focus: Durability of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies: Do you know how study designs influence the data with anti-vascular endothelial growth factor (anti-VEGF) therapies? Find out more. Earn Credit / Learning Objectives & Disclosures: by Keeping Current